Natera

NateraNatera
Natera

Natera

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Website
DR 722004Active5831Austin, United States
Rate
Advertise here

About

Natera is a clinical genetic testing company that develops and commercializes non-invasive prenatal testing (NIPT), oncology, and organ transplant rejection assessment tests. Their proprietary technology, based on the analysis of cell-free DNA, aims to provide highly accurate and personalized genetic information to patients and healthcare providers across various medical specialties.
Frequently asked

What does Natera do?

Natera is a clinical genetic testing company that develops and commercializes non-invasive prenatal testing (NIPT), oncology, and organ transplant rejection assessment tests. Their proprietary technology, based on the analysis of cell-free DNA, aims to provide highly accurate and personalized genetic information to patients and healthcare providers across various medical specialties.

What is Natera's revenue?

StartupHub estimates Natera's annual revenue at $1.1B (range $684.9M to $2.5B, 64% confidence), based on comparable companies in the sector.

What is Natera's valuation?

StartupHub estimates Natera's effective valuation at $193.3M (range $136.5M to $327.6M, 10% confidence), based on comparable companies in the sector.

How much funding has Natera raised?

Natera has raised a total of $55M in funding. The most recent round on record is Series E.

Where is Natera headquartered?

Natera is headquartered in Austin, United States.

When was Natera founded?

Natera was founded in 2004.

What industry does Natera operate in?

Natera operates in HealthTech, MedTech, Genomics, Clinical Trials, Oncology, Reproductive Health.

How many employees does Natera have?

Natera has approximately 5831 people on record.

HEADCOUNT
5831
DOMAIN RATING
72
Comments

No comments yet. Be the first to share your take.